Bluejay Diagnostics Files 2024 Annual Report Amendment
Ticker: BJDX · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1704287
Sentiment: neutral
Topics: amendment, annual-report, disclosures
TL;DR
Bluejay Diagnostics filed its amended 2024 10-K on 4/29/25. Check for updates.
AI Summary
Bluejay Diagnostics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 29, 2025, provides updated information for the company, which is incorporated in Delaware and headquartered in Acton, MA. The company operates in the surgical and medical instruments and apparatus industry.
Why It Matters
This amendment provides updated financial and operational information for investors and stakeholders, crucial for understanding the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to an annual report, typically containing updated disclosures rather than significant new risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for the annual report.)
- 001-41031 — SEC File Number (Unique identifier for the company's filings with the SEC.)
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Filer of the 10-K/A
- 2024 (date) — Fiscal year end for the report
- April 29, 2025 (date) — Filing date of the amendment
- Acton, MA (location) — Principal executive offices location
- 001-41031 (company) — SEC file number
FAQ
What specific information was updated in this Amendment No. 1 to the 10-K?
The filing is an amendment to the 10-K for the fiscal year ended December 31, 2024, indicating that updates or corrections were made to the original filing.
When was the original 10-K filed, and what is the purpose of this amendment?
The amendment was filed on April 29, 2025. Amendments are filed to correct or update information previously submitted in an SEC filing.
What is Bluejay Diagnostics, Inc.'s primary business sector?
Bluejay Diagnostics, Inc. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, with SIC code 3841.
Where are Bluejay Diagnostics, Inc.'s principal executive offices located?
The company's principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
What is the SEC file number for Bluejay Diagnostics, Inc.?
The SEC file number for Bluejay Diagnostics, Inc. is 001-41031.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).